Wangpan J. Shi

A Comprehensive Review of T-Cell Lymphoma Following CAR T-Cell Immunotherapy.

While chimeric antigen receptor (CAR) T-cell therapy provides potential cure for patients with non-Hodgkin B-cell lymphomas/leukemias and plasma cell myelomas, rare reports of development of T-cell lymphomas(TCLs) in these patients have raised serious safety concerns with regard to whether CAR T-cell therapy could dire...